First it was pork. Then mangoes and leafy greens. Now, Walmart is putting prescription drugs on blockchain in a pilot for the U.S. Food and Drug Administration (FDA).
The retailer and biopharmaceutical company Merck, along with IT company IBM and professional services firm KPMG, are participating in a program for the U.S. Drug Supply Chain Security Act (DSCSA), a 2013 regulation that is being phased in over the course of a decade and seeks to build an electronic system to trace certain prescription drugs as they are distributed in the U.S.
According
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in